• CureVac and Bayer Join Forces contractpharma
    January 08, 2021
    Bayer has signed a collaboration and services agreement with CureVac N.V., a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA).
PharmaSources Customer Service